BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36869893)

  • 1. Novel extracellular role of REIC/Dkk-3 protein in PD-L1 regulation in cancer cells.
    Gohara Y; Tomonobu N; Kinoshita R; Futami J; Audebert L; Chen Y; Komalasari NLGY; Jiang F; Yoshizawa C; Murata H; Yamamoto KI; Watanabe M; Kumon H; Sakaguchi M
    J Mol Med (Berl); 2023 Apr; 101(4):431-447. PubMed ID: 36869893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cysteine-rich core domain of REIC/Dkk-3 is critical for its effect on monocyte differentiation and tumor regression.
    Kinoshita R; Watanabe M; Huang P; Li SA; Sakaguchi M; Kumon H; Futami J
    Oncol Rep; 2015 Jun; 33(6):2908-14. PubMed ID: 25823913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer.
    Uchida D; Shiraha H; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Takaki A; Nouso K; Nasu Y; Yagi T; Kumon H; Yamamoto K
    J Gastroenterol Hepatol; 2014 May; 29(5):973-83. PubMed ID: 24372695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7.
    Sakaguchi M; Kataoka K; Abarzua F; Tanimoto R; Watanabe M; Murata H; Than SS; Kurose K; Kashiwakura Y; Ochiai K; Nasu Y; Kumon H; Huh NH
    J Biol Chem; 2009 May; 284(21):14236-44. PubMed ID: 19279003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internalization of REIC/Dkk-3 protein by induced pluripotent stem cell-derived embryoid bodies and extra-embryonic tissues.
    Kataoka K; Sakaguchi M; Li KP; Taketa C; Yamamoto K; Du G; Funahashi H; Murata H; Huh NH
    Int J Mol Med; 2010 Dec; 26(6):853-9. PubMed ID: 21042779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
    Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer.
    Shien K; Tanaka N; Watanabe M; Soh J; Sakaguchi M; Matsuo K; Yamamoto H; Furukawa M; Asano H; Tsukuda K; Nasu Y; Huh NH; Miyoshi S; Kumon H; Toyooka S
    PLoS One; 2014; 9(2):e87900. PubMed ID: 24498395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated REIC/Dkk-3 gene therapy: Development of an autologous cancer vaccination therapy (Review).
    Watanabe M; Nasu Y; Kumon H
    Oncol Lett; 2014 Mar; 7(3):595-601. PubMed ID: 24527065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation status of REIC/Dkk-3 gene in human malignancies.
    Hayashi T; Asano H; Toyooka S; Tsukuda K; Soh J; Shien T; Taira N; Maki Y; Tanaka N; Doihara H; Nasu Y; Huh NH; Miyoshi S
    J Cancer Res Clin Oncol; 2012 May; 138(5):799-809. PubMed ID: 22274868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising Gene Therapy Using an Adenovirus Vector Carrying REIC/Dkk-3 Gene for the Treatment of Biliary Cancer.
    Tanaka E; Uchida D; Shiraha H; Kato H; Ohyama A; Iwamuro M; Watanabe M; Kumon H; Okada H
    Curr Gene Ther; 2020; 20(1):64-70. PubMed ID: 32148193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The induction of antigen-specific CTL by in situ Ad-REIC gene therapy.
    Ariyoshi Y; Watanabe M; Eikawa S; Yamazaki C; Sadahira T; Hirata T; Araki M; Ebara S; Nasu Y; Udono H; Kumon H
    Gene Ther; 2016 May; 23(5):408-14. PubMed ID: 26836118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase.
    Abarzua F; Sakaguchi M; Takaishi M; Nasu Y; Kurose K; Ebara S; Miyazaki M; Namba M; Kumon H; Huh NH
    Cancer Res; 2005 Nov; 65(21):9617-22. PubMed ID: 16266978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression.
    Watanabe M; Kashiwakura Y; Huang P; Ochiai K; Futami J; Li SA; Takaoka M; Nasu Y; Sakaguchi M; Huh NH; Kumon H
    Int J Oncol; 2009 Mar; 34(3):657-63. PubMed ID: 19212670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.
    Shimazu Y; Kurozumi K; Ichikawa T; Fujii K; Onishi M; Ishida J; Oka T; Watanabe M; Nasu Y; Kumon H; Date I
    Gene Ther; 2015 Feb; 22(2):146-54. PubMed ID: 25394252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REIC/Dkk-3 induces cell death in human malignant glioma.
    Mizobuchi Y; Matsuzaki K; Kuwayama K; Kitazato K; Mure H; Kageji T; Nagahiro S
    Neuro Oncol; 2008 Jun; 10(3):244-53. PubMed ID: 18443132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3.
    Tanimoto R; Sakaguchi M; Abarzua F; Kataoka K; Kurose K; Murata H; Nasu Y; Kumon H; Huh NH
    Int J Cancer; 2010 Apr; 126(7):1562-9. PubMed ID: 19626590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector.
    Watanabe M; Sakaguchi M; Kinoshita R; Kaku H; Ariyoshi Y; Ueki H; Tanimoto R; Ebara S; Ochiai K; Futami J; Li SA; Huang P; Nasu Y; Huh NH; Kumon H
    Oncol Rep; 2014 Mar; 31(3):1089-95. PubMed ID: 24398705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis.
    Kashiwakura Y; Ochiai K; Watanabe M; Abarzua F; Sakaguchi M; Takaoka M; Tanimoto R; Nasu Y; Huh NH; Kumon H
    Cancer Res; 2008 Oct; 68(20):8333-41. PubMed ID: 18922905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
    Sawahara H; Shiraha H; Uchida D; Kato H; Kato R; Oyama A; Nagahara T; Iwamuro M; Horiguchi S; Tsutsumi K; Mandai M; Mimura T; Wada N; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Yagi T; Nasu Y; Kumon H; Okada H
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1769-1777. PubMed ID: 28168749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An N-terminal 78 amino acid truncation of REIC/Dkk-3 effectively induces apoptosis.
    Abarzua F; Kashiwakura Y; Takaoka M; Watanabe M; Ochiai K; Sakaguchi M; Iwawaki T; Tanimoto R; Nasu Y; Huh NH; Kumon H
    Biochem Biophys Res Commun; 2008 Oct; 375(4):614-8. PubMed ID: 18727918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.